Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic LeukemiaMatthew S. Davids, John F. Seymour, Stephan Stilgenbauer et al.|Clinical Cancer Research|2018Cited by 161
Safety Profile of Venetoclax Monotherapy in Patients with Chronic Lymphocytic LeukemiaJohn F. Seymour, Stephan Stilgenbauer, Matthew S. Davids et al.|Blood|2016Cited by 10